Phylogica Of Australia Inks Vaccine-Making Deal With Pfizer Of U.S.
This article was originally published in PharmAsia News
Executive Summary
Australia's Phylogica biotech has signed a drug-development deal with U.S. drug-maker Pfizer for peptide-based vaccines